Viewing nowCystat Tablets 40 mg (Simvastatin)
Simvastatin 40mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

MFDS item code 200300941 · Notified 2003.06.02 · Insurance code 641902730
Improvement of hyperlipidemia (including familial hypercholesterolemia in children) and reduction of cardiovascular disease risk
This medication has the efficacy of reducing the risk of cardiovascular diseases. It reduces the risk of coronary events, myocardial infarction, and stroke in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, or stroke. It also helps to lower the risk of complications after vascular procedures. It is used to treat hyperlipidemia and improves various dyslipidemia conditions, including primary hypercholesterolemia, familial and non-familial dyslipidemia, and hypertriglyceridemia. It is used effectively to lower cholesterol levels in young children with familial hypercholesterolemia in conjunction with dietary measures. This medication is used comprehensively to promote cardiovascular health and reduce risks.
Before and during treatment with this drug, patients must follow a standard cholesterol-lowering diet. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. Administration of 5 ~ 40 mg of this drug once daily in the evening is recommended. Adjust the dose appropriately according to the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this drug, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) For recommended doses in patients receiving this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), see below (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on controlled clinical trial results, administer 40 mg of this drug once daily in the evening to patients with homozygous familial hypercholesterolemia. Administer this drug in combination with other lipid-lowering therapy (e.g., LDL apheresis), or when other lipid-lowering therapy is not possible. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this drug. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this drug is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this drug should not exceed 10 mg daily. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this drug is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this drug should not exceed 20 mg daily. (5) Concomitant administration with other lipid-lowering drugs This drug is effective when administered alone or in combination with a bile acid sequestrant. When this drug is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this drug should not exceed 10 mg daily. (6) Administration to patients with renal impairment Because this drug is not extensively excreted by the kidneys, dose adjustment is not necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg daily and monitor carefully.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.
This medication primarily acts in the liver to lower blood cholesterol levels. However, it may affect muscles and cause symptoms such as muscle pain or weakness. The risk of muscle damage may be higher, especially when taking high doses, so caution is needed. If symptoms like muscle pain, tenderness, or weakness occur during treatment, it is necessary to consult a doctor immediately. Patients with liver dysfunction or active liver disease should not take this medication. Women who are pregnant, potentially pregnant, or breastfeeding should not take this medication. Also, taking this medication with certain antifungal agents, antibiotics, immunosuppressants, or blood pressure medications can increase the risk of muscle damage; therefore, be sure to inform the doctor of all medications currently being taken. This medication can affect liver function, so regular liver function tests are advisable. Elderly patients or those with impaired renal function are at a higher risk of muscle damage while taking this medication and should be monitored closely. While taking this medication, it is advisable to avoid certain foods such as grapefruit juice, and it is safe to limit alcohol consumption during treatment. This medication is restricted for use in children, specifically in patients with certain hypercholesterolemia conditions, and should not be administered to children under 10 years of age. If any abnormal symptoms appear during treatment, immediate consultation with medical staff is essential, and care should be taken not to discontinue the medication on your own.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a sealed container. The storage temperature should be between 1 and 30 degrees Celsius, and it is advisable to avoid very hot or very cold places.
Pale pink oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 40mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.